Sign in

CIK 0002079109

  • Emerging growth company

Veraxa Biotech AG - Post de-SPAC

Sign in to watch
Ticker
VRXA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Switzerland
Entity type
Other
Phone
+41 443858450
Business address
TALACKER 35, ZURICH, Switzerland, 8001
Former names
Veraxa Biotech Holding AG

Securities

  • VRXA Ordinary Shares Nasdaq
  • VRXAW Warrants Nasdaq
Open-market buys, last 90 days
$125,333
in 4 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$125,333. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-10-28 Gruninger Marc Director Purchase +9,133 $1.00 $9K 10,000
2026-10-27 Gruninger Marc Director Purchase +867 $0.98 $850 867
2026-10-20 Ziegler Christoph Samuel Director Purchase +30,000 $1.09 $33K 37,932
2026-08-27 Baumann Oliver Rolf Director Purchase +50,000 $1.50 $75K 5,773,618
2026-08-27 Antz Christoph Rudiger Chief Executive Officer Purchase +5,000 $1.53 $8K 5,000

Page 1 of 1 · 5 trades